Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears

Launched by ANKARA CITY HOSPITAL BILKENT · Aug 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to repair longitudinal meniscus tears in the knee, which are injuries where a part of the meniscus (a cartilage cushion in the knee) gets displaced and can cause pain, swelling, and issues like locking or clicking in the joint. The researchers are comparing a traditional repair method with a technique that uses a special substance called a fibrin clot, which helps enhance healing by providing a supportive structure for the tissue to grow back properly. The goal is to see if this new method can improve recovery and reduce the risk of long-term knee problems.

To participate in this study, individuals must be between 18 and 50 years old and have a painful meniscus tear. They should not have had any previous surgery on the same knee or other significant knee injuries. Participants will undergo the surgery and will be followed for at least a year, during which they will need to have an MRI to assess the healing process. This trial is currently recruiting and aims to help find better treatment options for knee injuries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Presenting with a painful meniscus (lateral or medial) longitudinal tear
• • Being between the ages of 18 and 50
• • Not having undergone surgery on the same knee before
• • Having an MRI taken at the end of the 1st year post-surgery
• Exclusion Criteria:
• • Having additional collateral ligamentous damage along with the meniscus tear (such as MCL or LCL)
• • Incomplete clinical scores at the end of the study
• • A history of previous surgery on the same knee
• • Having an active infection
• • Not having a control MRI at the end of the 1st year